U.S. Stock Insider Trading | PROCEPT BioRobotics disclosed two insider trading transactions on March 12.

K-LinePoet · 2026-04-08T15:25:06+00:00

PROCEPT BioRobotics recently disclosed internal trading activity, with executive Nouri Alaleh selling 3,098 shares on March 10, 2026. Additionally, director Desai Antal Rohit made multiple stock purchases on the same day, demonstrating confidence in the company's future. The company focuses on developing urological surgical robots to improve patient care quality.

K-LinePoet

2026-04-08 15:25:06

Abstract generation in progress

On March 12, 2026, PROCEPT BioRobotics (PRCT) disclosed two transactions involving company insiders. Executive Nouri Alaleh sold 3,098 shares on March 10, 2026.

[Recent Insider Transactions]

Disclosure Date	Position	Name	Transaction Date	Buy/Sell	Quantity	Price per Share/US$	Total Amount/US$
Mar 12, 2026	Executive	Nouri Alaleh	Mar 10, 2026	Sell	3,098	25.60	79.30k
Mar 12, 2026	Executive	Nouri Alaleh	Mar 10, 2026	Sell	145	26.74	3,877.00
Mar 9, 2026	Director	Desai Antal Rohit	Mar 9, 2026	Buy	1,300	25.42	33.00k
Mar 9, 2026	Director	Desai Antal Rohit	Mar 6, 2026	Buy	106,000	23.33	2.4857 million
Mar 9, 2026	Director	Desai Antal Rohit	Mar 6, 2026	Buy	53,800	24.10	1.2958 million
Mar 9, 2026	Director	Desai Antal Rohit	Mar 9, 2026	Buy	53,800	24.91	1.3403 million
Mar 9, 2026	Director	Desai Antal Rohit	Mar 9, 2026	Buy	43,600	24.08	1.0495 million
Mar 9, 2026	Director	Desai Antal Rohit	Mar 5, 2026	Buy	142,500	25.44	3.6250 million
Mar 9, 2026	Director	Desai Antal Rohit	Mar 5, 2026	Buy	24,700	26.41	653,500
Mar 9, 2026	Executive	Waters Kevin	Mar 6, 2026	Sell	6,721	23.70	1.5930 million

[Company Profile]

PROCEPT BioRobotics Corporation was incorporated in 2007 in California. In April 2021, the company was re-incorporated in Delaware. The company is a commercial-stage surgical robotics company, focused on advancing patient care by developing transformative solutions in urology. They develop, manufacture, and sell the AquaBeam robot system, an advanced image-guided surgical robotics system for minimally invasive urological surgeries, initially focused on treating benign prostatic hyperplasia, or BPH.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes